Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 4, 2020
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosisJames F Chmiel, Patrick Flume, Damian G Downey, et al.
International Journal of Antimicrobial Agents|September 24, 2014
Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?John E Moore, Michael Alcorn, Wakana Ara, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 8, 2014
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase)Jill Deacon, Sharif M Abdelghany, Derek J Quinn, et al.
American Journal of Respiratory and Critical Care Medicine|March 28, 2009
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteersMurali Shyamsundar, Scott T W McKeown, Cecilia M O'Kane, et al.
Scientific Reports|January 17, 2017
Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibioticHussein Chalhoub, Daniel Pletzer, Helge Weingart, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2018
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
The European Respiratory Journal|January 13, 2018
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis NetworkJames D Chalmers, Felix C Ringshausen, Bridget Harris, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2019
Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosisPavel Drevinek, Tacjana Pressler, Marco Cipolli, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2014
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosisYasunori Maeda, Mayumi Murayama, Colin E Goldsmith, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 4, 2020
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosisJames F Chmiel, Patrick Flume, Damian G Downey, et al.
International Journal of Antimicrobial Agents|September 24, 2014
Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?John E Moore, Michael Alcorn, Wakana Ara, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 8, 2014
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase)Jill Deacon, Sharif M Abdelghany, Derek J Quinn, et al.
American Journal of Respiratory and Critical Care Medicine|March 28, 2009
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteersMurali Shyamsundar, Scott T W McKeown, Cecilia M O'Kane, et al.
Scientific Reports|January 17, 2017
Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibioticHussein Chalhoub, Daniel Pletzer, Helge Weingart, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2018
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
The European Respiratory Journal|January 13, 2018
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis NetworkJames D Chalmers, Felix C Ringshausen, Bridget Harris, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2019
Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosisPavel Drevinek, Tacjana Pressler, Marco Cipolli, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2014
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsLaura J Sherrard, Bettina Schaible, Kathryn A Graham, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosisYasunori Maeda, Mayumi Murayama, Colin E Goldsmith, et al.
Pageof 29